Ergebnis der Suchanfrage nach @suche@D&ampuumlsseldorf

Titian Software; Labguru

Keith Hale appointed as Group CEO to Unite Titian Software & Labguru (BioData)

London (ots/PRNewswire) - Keith Hale has been appointed as Group CEO of Titian Software and Labguru (BioData Inc.), two leading providers of laboratory data management solutions, as part of the goal to accelerate the future of digital lab operations. A well-known fintech executive, Keith brings 33 years of growth-focused software and technology leadership. He ...

DYMO Deutschland

DYMO PARTNERS WITH GA INTERNATIONAL (LABTAG) TO OFFER CRYOGENIC LABELS FOR DYMO LABELWRITER 5 SERIES PRINTERS

Hellmann Worldwide Logistics

Hellmann appoints Gilles Duffaut as new Managing Director France

Helmholtz Munich

Ancient Viral DNA Shapes Early Embryo Development

Over half of our genomes consists of thousands of remnants of ancient viral DNA, known as transposable elements, which are widespread across the tree of life. Once dismissed as the "dark side" of the genome, researchers at Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have now revealed their crucial role in early embryo development. Unanswered Questions About the Role of Ancient Viral DNA Transposable ...

INFOSYS

Infosys: Strong growth of 6.1% YoY in CC, 80 bps YoY operating margin expansion

Bengaluru, India (ots/PRNewswire) - - Large deal TCV of $2.5 billion including 63% net new; Headcount increased by 5,591 - FY25 revenue guidance revised to 4.5%-5.0% Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered strong and broad-based performance with $4,939 million in Q3 revenues, growth of ...

Helmholtz Munich

SCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues

Bosch Healthcare Solutions GmbH

Vivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergencies

Grünenthal Group

Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer

BIAL SA

BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease

Porto, Portugal (ots/PRNewswire) - BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE Phase 2 study. BIA 28-6156 is a first-in-class, small molecule for once-daily oral ...

Norgine

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...

nova-Institut GmbH

6

Transforming CO₂ into Opportunities: The CO₂-Based Fuels and Chemicals Conference 2025

INFOSYS

Infosys Strengthens Strategic Collaboration with Google Cloud to Boost Enterprise AI Innovation, Establishes Center of Excellence

Bengaluru, India (ots/PRNewswire) - Leveraging Infosys Topaz and Google Cloud technology, the center of excellence will foster co-innovation to deliver transformative AI-powered solutions Infosys (NSE: INFY), (BSE: INFY), (NYSE: INFY), a global leader in next-generation digital services and consulting, today ...

Accord Healthcare

Accord Healthcare is granted marketing authorisation for IMULDOSA®, ustekinumab biosimilar to Stelara®

London (ots/PRNewswire) - - Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immune medicated inflammatory diseases. - The EC approval follows a positive opinion issued on 19 October ...

Hellmann Worldwide Logistics

Hellmann: Martin Habisreitinger appointed COO Airfreight

Helmholtz Munich

Maria-Elena Torres-Padilla Honored With the Leibniz Prize 2025

Hellmann Worldwide Logistics

3

Hellmann helps supports voluntary engagement

Helmholtz Munich

Inceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies

Technische Universität München

New method for designing artificial proteins

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Designing large new proteins with AI New method for designing artificial proteins - Efficient design of new proteins with desired properties - Size of newly designed proteins is approaching that of antibodies - Predicted protein structures successfully validated in experiments Protein design aims to create customized antibodies for therapies, biosensors for diagnostics, or ...

Hellmann Worldwide Logistics

2

Hellmann advances innovation with AI-RobotX MEA and Geekplus to enhance eCommerce fulfillment operations

nova-Institut GmbH

6

Capture, Convert, and Conquer: Innovations Wanted for the “Best CO₂ Utilisation 2025” Innovation Award

Lamilux Heinrich Strunz GmbH

LAMILUX AntiBac Wins “Best Food Safety Innovation of the Decade” at the Gulfood Manufacturing Awards 2024

Lamilux Heinrich Strunz GmbH

5

LAMILUX renovation solutions: Customised, cost-effective and energy-efficient!

Hellmann Worldwide Logistics

2

Hellmann launches next growth phase with new global leadership structure

nova-Institut GmbH

5

Advanced Recycling Conference 2024 – Driving Innovation in Sustainable Materials Management